Grey Matters Health signs LOI with Catalyst MedTech for 200 brain PET scans

  • Grey Matters Health signed a non-binding LOI with Catalyst MedTech to provide at least 200 brain PET scans for an Alzheimer’s clinical trial run by an international AD-focused CRO.
  • The scans are slated for its second planned NovaScan neuroimaging clinic in Tampa, Florida, targeted to be established by end-Q4 2026.
  • The parties are working toward a definitive services agreement within 60 days.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grey Matters Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605200700PRIMZONEFULLFEED9723832) on May 20, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.